Stone Christopher Lewis 4
4 · PDL BIOPHARMA, INC. · Filed Jan 28, 2013
Insider Transaction Report
Form 4
Stone Christopher Lewis
VP and General Counsel
Transactions
- Award
Common Stock
2013-01-24$6.72/sh+16,458$110,598→ 76,670 total
Footnotes (1)
- [F1]The shares will vest on December 12, 2014, provided Mr. Stone is continuously employed by the Company through such date. In the event Mr. Stone is terminated by PDLI without cause or resigns for good reason, the shares shall ratably accelerate and vest in proportion to the time lapsed during the vesting period. During the vesting period, Mr. Stone has the right to vote the shares and will receive any dividends and other shareholder distributions paid by PDLI. Such dividends and other distributions shall accumulate with interest and will vest and pay if and when the underlying shares vest.